HUT63464A - Process for producing ciliary neurotrophic factor receptor - Google Patents

Process for producing ciliary neurotrophic factor receptor

Info

Publication number
HUT63464A
HUT63464A HU923772A HU377292A HUT63464A HU T63464 A HUT63464 A HU T63464A HU 923772 A HU923772 A HU 923772A HU 377292 A HU377292 A HU 377292A HU T63464 A HUT63464 A HU T63464A
Authority
HU
Hungary
Prior art keywords
cntf
neurotrophic factor
ciliary neurotrophic
factor receptor
relates
Prior art date
Application number
HU923772A
Other languages
English (en)
Other versions
HU9203772D0 (en
Inventor
Samuel Davis
Stephen P Squinto
Mark E Furth
George D Yancopoulos
Original Assignee
Regeneron Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US07/676,647 external-priority patent/US5426177A/en
Application filed by Regeneron Pharma filed Critical Regeneron Pharma
Publication of HU9203772D0 publication Critical patent/HU9203772D0/hu
Publication of HUT63464A publication Critical patent/HUT63464A/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/40—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation
    • C07K2319/41—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation containing a Myc-tag
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
    • C07K2319/74—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor
    • C07K2319/75—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor containing a fusion for activation of a cell surface receptor, e.g. thrombopoeitin, NPY and other peptide hormones
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Wood Science & Technology (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Analytical Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Cell Biology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Compounds Of Unknown Constitution (AREA)
HU923772A 1990-06-01 1991-06-03 Process for producing ciliary neurotrophic factor receptor HUT63464A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US53228590A 1990-06-01 1990-06-01
US07/676,647 US5426177A (en) 1990-06-01 1991-03-28 Ciliary neurotrophic factor receptor
US70067791A 1991-05-15 1991-05-15

Publications (2)

Publication Number Publication Date
HU9203772D0 HU9203772D0 (en) 1993-03-29
HUT63464A true HUT63464A (en) 1993-08-30

Family

ID=27415086

Family Applications (2)

Application Number Title Priority Date Filing Date
HU923772A HUT63464A (en) 1990-06-01 1991-06-03 Process for producing ciliary neurotrophic factor receptor
HU95P/P00737P HU211976A9 (en) 1990-06-01 1995-06-30 The ciliary neurotrophic factor receptor

Family Applications After (1)

Application Number Title Priority Date Filing Date
HU95P/P00737P HU211976A9 (en) 1990-06-01 1995-06-30 The ciliary neurotrophic factor receptor

Country Status (14)

Country Link
EP (1) EP0533846B1 (hu)
JP (1) JP3266611B2 (hu)
AT (1) ATE195341T1 (hu)
AU (1) AU656732B2 (hu)
CA (1) CA2084075C (hu)
DE (1) DE69132361T2 (hu)
FI (1) FI925457A0 (hu)
HU (2) HUT63464A (hu)
IE (1) IE911867A1 (hu)
IL (1) IL98304A (hu)
LV (1) LV10312B (hu)
NO (1) NO924614L (hu)
PT (1) PT97821A (hu)
WO (1) WO1991019009A1 (hu)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5169764A (en) * 1990-08-08 1992-12-08 Regeneron Pharmaceuticals, Inc. Multitrophic and multifunctional chimeric neurotrophic factors, and nucleic acids and plasmids encoding the chimeras
US5360740A (en) * 1992-07-02 1994-11-01 Regeneron Pharmaceuticals, Inc. Assay system for degenerative muscle disease
US6472178B1 (en) 1998-02-27 2002-10-29 Regeneron Pharmaceuticals, Inc. Nucleic acids encoding a modified ciliary neurotrophic factor and method of making thereof
AU6130094A (en) * 1993-01-29 1994-08-15 Regeneron Pharmaceuticals, Inc. Methods of treatment using ciliary neurotrophic factor
WO1995007467A1 (en) * 1993-09-09 1995-03-16 Regeneron Pharmaceuticals, Inc. Assay systems using the cntf signal transduction pathway
DE4331297A1 (de) * 1993-09-15 1995-03-16 Henkel Kgaa Stückseifen
WO2001089550A2 (en) * 2000-05-24 2001-11-29 Regeneron Pharmaceuticals, Inc. Use of ciliary neurotrophic factor
US20200297868A1 (en) * 2016-12-14 2020-09-24 University Of Cincinnati Methods and compositions for the treatment of als
CN113607714B (zh) * 2021-10-08 2022-01-11 成都齐碳科技有限公司 分子膜成膜或表征器件、装置、方法以及生物芯片

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5017375A (en) * 1982-11-24 1991-05-21 Baylor College Of Medicine Method to prepare a neurotrophic composition
US4923696A (en) * 1987-05-04 1990-05-08 Baylor College Of Medicine Method to prepare a neurotrophic composition
US4997929A (en) * 1989-01-05 1991-03-05 Synergen, Inc. Purified ciliary neurotrophic factor
US5011914A (en) * 1989-01-05 1991-04-30 Collins Franklin D Purified ciliary neurotrophic factor
IE903130A1 (en) * 1989-09-15 1991-03-27 Regeneron Pharma Ciliary neurotrophic factor
AR243237A1 (es) * 1990-03-14 1993-07-30 Fidia Spa Un vector de expresion recombinante que contiene una secuencia de adn que codifica el factor neurotrofico ciliar humano,un microorganismo e.coli transformado,y linea celulares transformadas.
IT1247150B (it) * 1991-01-21 1994-12-12 Fidia Spa Processo per la sintesi e la purificazione del fattore neuronotroficociliare umano (cntf) da escherichia coli.

Also Published As

Publication number Publication date
FI925457A (fi) 1992-11-30
IL98304A0 (en) 1992-06-21
LV10312A (lv) 1994-10-20
EP0533846B1 (en) 2000-08-09
AU656732B2 (en) 1995-02-16
NO924614D0 (no) 1992-11-30
PT97821A (pt) 1992-02-28
HU211976A9 (en) 1996-01-29
EP0533846A4 (hu) 1994-04-27
JPH06507062A (ja) 1994-08-11
LV10312B (en) 1995-10-20
IE911867A1 (en) 1991-12-04
DE69132361D1 (de) 2000-09-14
FI925457A0 (fi) 1992-11-30
IL98304A (en) 2008-08-07
AU8233791A (en) 1991-12-31
CA2084075A1 (en) 1991-12-02
CA2084075C (en) 2005-08-16
DE69132361T2 (de) 2001-03-29
EP0533846A1 (en) 1993-03-31
ATE195341T1 (de) 2000-08-15
WO1991019009A1 (en) 1991-12-12
HU9203772D0 (en) 1993-03-29
JP3266611B2 (ja) 2002-03-18
NO924614L (no) 1993-01-21

Similar Documents

Publication Publication Date Title
HUT54624A (en) Process for producing cyclic amino-acid derivatives and theyr intermediates
EP1361229A3 (en) Use of Tyrosine Kinase (PYK2) to produce antibodies
EP0441947A4 (en) Neurotrophin-3, a novel neurotrophic factor related to nerve growth factor and brain derived neurotrophic factor
KR920701432A (ko) 뇌유도성 향신경성 인자
NO873753D0 (no) Periodisk biologisk luftbehandlingsprosess og system for denne.
ATE107362T1 (de) Polypeptid-mutanten des menschlichen tnf und für diese mutanten codierende dns.
HUT63464A (en) Process for producing ciliary neurotrophic factor receptor
ZA86217B (en) Dna sequences,recombinant dna molecules and processes for producing human lipocortin-like polypeptides
DE69333491D1 (en) Protease-resistente analoge des thrombomodulin
EP0267297A4 (en) SIALOSYLCHOLESTEROL, PROCESS FOR THE PREPARATION AND MEDICINE AGAINST DISORDERS OF THE NERVOUS SYSTEM.
AU5202186A (en) Method for biological testing and/or developing pharmaceuticals for treatment of disorders
Beckmann Phenylalanine in affective disorders.
PT990000E (pt) Factor 3 de crescimento do tecido conjuntivo
EP0214548A3 (en) Dna sequences, recombinant dna molecules and process for the preparation of the enzyme mutarotase of acinetobacter calcoaceticus
IT8622049A0 (it) Metodo per la determinazione dell'attivita' biologica della proteina c nel plasma umano, e relativi reagenti.
Shabatura Mechanism of the origin of infradian biological rhythms(Mekhanizm proiskhozhdeniia infradiannykh biologicheskikh ritmov)
DE69832371D1 (de) Varianten des neurotrophischen ziliarischen faktors mit erhöhter rezeptor-selektivität und verfahren zu deren auswahl
IT8647992A0 (it) Metodo per il trattamento di malattie autoimmunitarie,basato sull'uso del bendazac e di altri farmaci che inibiscono specificamente i processi di denaturazione proteica responsabili della reazione autoimmunitaria
UA15554A (uk) Спосіб прогhозуваhhя ефективhості рефлексотерапії за лазориком
GB2333527A (en) Therapeutic gene
GB0120923D0 (en) System and method for identifying nucleic acid molecules,polypeptides and uses therefor,including diagnosis and treatment of neurological disorders
GB0128182D0 (en) System and method for identifying nucleic acid molecules,polypeptides and uses therefor,including diagnosis and treatment of neurological disorders

Legal Events

Date Code Title Description
DFD9 Temporary protection cancelled due to non-payment of fee